Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-18 · accession 0001628280-25-006516 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-19 | 2025-02-18 | VIR | SCANGOS GEORGE A | Dir | S - Sale | $9.81 | -11.0K | 708.3K | -2% | -$107.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-18 | S | D | 10,964 | $9.81 | 708,295 | D | — | — |